These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21074998)

  • 1. Synthesis, binding studies and molecular modeling of novel cannabinoid receptor ligands.
    Osman NA; Mahmoud AH; Allarà M; Niess R; Abouzid KA; Di Marzo V; Abadi AH
    Bioorg Med Chem; 2010 Dec; 18(24):8463-77. PubMed ID: 21074998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New resorcinol-anandamide "hybrids" as potent cannabinoid receptor ligands endowed with antinociceptive activity in vivo.
    Brizzi A; Brizzi V; Cascio MG; Corelli F; Guida F; Ligresti A; Maione S; Martinelli A; Pasquini S; Tuccinardi T; Di Marzo V
    J Med Chem; 2009 Apr; 52(8):2506-14. PubMed ID: 19331413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of novel tail-modified anandamide analogs.
    Yao F; Li C; Vadivel SK; Bowman AL; Makriyannis A
    Bioorg Med Chem Lett; 2008 Nov; 18(22):5912-5. PubMed ID: 18723350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of endocannabinoid-based chemical probes for the study of cannabinoid receptors.
    Martín-Couce L; Martín-Fontecha M; Capolicchio S; López-Rodríguez ML; Ortega-Gutiérrez S
    J Med Chem; 2011 Jul; 54(14):5265-9. PubMed ID: 21675776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and binding studies of new potent ligands of cannabinoid receptors.
    Brizzi A; Brizzi V; Cascio MG; Bisogno T; Sirianni R; Di Marzo V
    J Med Chem; 2005 Nov; 48(23):7343-50. PubMed ID: 16279794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability.
    Lin S; Khanolkar AD; Fan P; Goutopoulos A; Qin C; Papahadjis D; Makriyannis A
    J Med Chem; 1998 Dec; 41(27):5353-61. PubMed ID: 9876105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and pharmacological evaluation of sulfamide-based analogues of anandamide.
    Cano C; Páez JA; Goya P; Serrano A; Pavón J; Rodríguez de Fonseca F; Suardíaz M; Martín MI
    Eur J Med Chem; 2009 Dec; 44(12):4889-95. PubMed ID: 19762126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, cannabinoid receptor activity, and enzymatic stability of reversed amide derivatives of arachidonoyl ethanolamide.
    Parkkari T; Savinainen JR; Raitio KH; Saario SM; Matilainen L; Sirviö T; Laitinen JT; Nevalainen T; Niemi R; Järvinen T
    Bioorg Med Chem; 2006 Aug; 14(15):5252-8. PubMed ID: 16644227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors.
    Priller J; Briley EM; Mansouri J; Devane WA; Mackie K; Felder CC
    Mol Pharmacol; 1995 Aug; 48(2):288-92. PubMed ID: 7651362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors.
    Melck D; Bisogno T; De Petrocellis L; Chuang H; Julius D; Bifulco M; Di Marzo V
    Biochem Biophys Res Commun; 1999 Aug; 262(1):275-84. PubMed ID: 10448105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors.
    Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M
    Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown.
    Reggio PH
    Curr Med Chem; 2010; 17(14):1468-86. PubMed ID: 20166921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical synthesis, pharmacological characterization, and possible formation in unicellular fungi of 3-hydroxy-anandamide.
    De Petrocellis L; Deva R; Mainieri F; Schaefer M; Bisogno T; Ciccoli R; Ligresti A; Hill K; Nigam S; Appendino G; Di Marzo V
    J Lipid Res; 2009 Apr; 50(4):658-66. PubMed ID: 19017617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear magnetic resonance for studying recognition processes between anandamide and cannabinoid receptors.
    Bonechi C; Martini S; Brizzi V; Brizzi A; Massarelli P; Bruni G; Rossi C
    Eur J Med Chem; 2006 Oct; 41(10):1117-23. PubMed ID: 16837109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New metabolically stable fatty acid amide ligands of cannabinoid receptors: Synthesis and receptor affinity studies.
    Urbani P; Cavallo P; Cascio MG; Buonerba M; De Martino G; Di Marzo V; Saturnino C
    Bioorg Med Chem Lett; 2006 Jan; 16(1):138-41. PubMed ID: 16213718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists.
    Ashton JC; Wright JL; McPartland JM; Tyndall JD
    Curr Med Chem; 2008; 15(14):1428-43. PubMed ID: 18537620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, pharmacological evaluation and electrochemical studies of novel 6-nitro-3,4-methylenedioxyphenyl-N-acylhydrazone derivatives: Discovery of LASSBio-881, a new ligand of cannabinoid receptors.
    Duarte CD; Tributino JL; Lacerda DI; Martins MV; Alexandre-Moreira MS; Dutra F; Bechara EJ; De-Paula FS; Goulart MO; Ferreira J; Calixto JB; Nunes MP; Bertho AL; Miranda AL; Barreiro EJ; Fraga CA
    Bioorg Med Chem; 2007 Mar; 15(6):2421-33. PubMed ID: 17275312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, conformational analysis and CB1 binding affinity of hairpin-like anandamide pseudopeptide mimetics.
    Di Marzo M; Casapullo A; Bifulco G; Cimino P; Ligresti A; Di Marzo V; Riccio R; Gomez-Paloma L
    J Pept Sci; 2006 Sep; 12(9):575-91. PubMed ID: 16534762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Membrane cholesterol mediates the endocannabinoids-anandamide affection on HepG2 cells].
    Wu WJ; Yang Q; Cao QF; Zhang YW; Xia YJ; Hu XW; Tang WX
    Zhonghua Gan Zang Bing Za Zhi; 2010 Mar; 18(3):204-8. PubMed ID: 20380798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological evaluation of pyridone alkaloids on the endocannabinoid system.
    Chicca A; Berg R; Jessen HJ; Marck N; Schmid F; Burch P; Gertsch J; Gademann K
    Bioorg Med Chem; 2017 Nov; 25(22):6102-6114. PubMed ID: 28284861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.